Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7
- PMID: 11016877
Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7
Abstract
Problem/condition: An increasing proportion of adults have received recommended vaccinations against influenza, pneumococcal infection, and tetanus. However, in 1995, fewer than 60% of adults were vaccinated as recommended.
Reporting period covered: 1993-1997.
Description of system: Data were obtained from the state-based Behavioral Risk Factor Surveillance System (BRFSS) for 1993, 1995, and 1997 and from the National Health Interview Survey (NHIS) for 1995 to describe national, regional, and state-specific patterns of use of influenza and pneumococcal vaccines and tetanus toxoid among noninstitutionalized adults aged > or = 18 years.
Results: Among adults aged > or = 65 years in 1995, 58% reported receiving an influenza vaccination during the previous 12 months, and 34% reported ever receiving a pneumococcal vaccination. In this age group, non-Hispanic whites were more likely to report receipt of influenza (61%) and pneumococcal vaccines (36%) than non-Hispanic blacks (40% and 22%, respectively) and Hispanics (50% and 23%, respectively). Among the 50 states and the District of Columbia, the median vaccination level among older adults (i.e., persons aged > or = 65 years) increased from 51% in 1993 to 66% in 1997 for influenza vaccine, and from 28% in 1993 to 46% in 1997 for pneumococcal vaccine. Adults with chronic medical conditions had low vaccination levels. Those aged 50-64 years were more likely than those aged 18-49 years to report influenza (38% versus 20%) and pneumococcal vaccination (20% versus 12%). In 1995, the proportion of adults who reported receiving a tetanus vaccination during the previous 10 years decreased with age, from 65% among those aged 18-49 years to 54% among those aged 50-64 years and to 40% among those aged > or = 65 years. In each age group, women were less likely than men to report receiving tetanus toxoid; and among adults aged > or = 65 years, Hispanics and Asians/Pacific Islanders were least likely among all racial/ethnic groups to report receiving tetanus toxoid.
Interpretation: By 1995, the Healthy People 2000 objective to increase to at least 60% the proportion of persons aged > or = 65 years who had received annual influenza vaccination had been achieved among non-Hispanic whites (objective 20.11). However, substantial improvement is needed among non-Hispanic blacks, Hispanics, and adults aged < 65 years with high-risk medical conditions.
Public health actions: Continued surveillance of vaccine coverage among adults will direct attention to undervaccinated populations that may be disproportionately affected by vaccine-preventable diseases. Vaccination coverage data can be used to guide efforts to increase awareness among health-care providers and the public about the benefits of vaccination, establish systems to ensure that every contact with the health-care system is used to update vaccinations, and further support financial mechanisms to increase vaccine delivery.
Similar articles
-
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1. MMWR Surveill Summ. 2021. PMID: 33983910 Free PMC article.
-
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1. MMWR Surveill Summ. 2016. PMID: 26844596
-
Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.MMWR Surveill Summ. 2017 May 5;66(11):1-28. doi: 10.15585/mmwr.ss6611a1. MMWR Surveill Summ. 2017. PMID: 28472027 Free PMC article.
-
Vaccines for older adults.Consult Pharm. 2009 May;24(5):380-91. doi: 10.4140/tcp.n.2009.380. Consult Pharm. 2009. PMID: 19555147 Review.
-
Vaccinations.Clin Geriatr Med. 1992 Nov;8(4):745-60. Clin Geriatr Med. 1992. PMID: 1423132 Review.
Cited by
-
Prevalence and correlates of influenza vaccination among non-institutionalized elderly people: an exploratory cross-sectional survey.Int J Nurs Stud. 2009 Jun;46(6):768-77. doi: 10.1016/j.ijnurstu.2008.12.006. Epub 2009 Jan 21. Int J Nurs Stud. 2009. PMID: 19162264 Free PMC article.
-
Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.Epidemiol Infect. 2008 Mar;136(3):360-9. doi: 10.1017/S0950268807008436. Epub 2007 Apr 20. Epidemiol Infect. 2008. PMID: 17445314 Free PMC article.
-
Racial/ethnic differences in influenza vaccination coverage in high-risk adults.Am J Public Health. 2003 Dec;93(12):2074-8. doi: 10.2105/ajph.93.12.2074. Am J Public Health. 2003. PMID: 14652337 Free PMC article.
-
Influenza vaccination in adults with chronic obstructive pulmonary disease: the impact of a diagnostic breathing test on vaccination rates.PLoS One. 2013 Jun 28;8(6):e67600. doi: 10.1371/journal.pone.0067600. Print 2013. PLoS One. 2013. PMID: 23840746 Free PMC article.
-
Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.J Am Geriatr Soc. 2010 Dec;58(12):2323-8. doi: 10.1111/j.1532-5415.2010.03181.x. J Am Geriatr Soc. 2010. PMID: 21143440 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials